Código QR (código de barras bidimensional)

Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis

Introduction: Fingolimod is the first confirmed oral immune-modulator to treat Relapsing-Remitting Multiple Sclerosis (RRMS). This study aimed to investigate the safety and efficacy of fingolimod therapy in Iranian patients with RRMS. Methods: In our trial, 50 patients resistant to conventional inte...

ver descrição completa

Na minha lista:
Principais autores: Fatemeh Yavari, Pardis Oliazadeh, Meisam Radfar, Mohsen Foroughipour, Karim Nikkhah, Alireza Heidari Bakavoli, Morteza Saeidi
Formato: Artigo
Idioma:Inglês
Publicado em: Iran University of Medical Sciences 2021-03-01
coleção:Basic and Clinical Neuroscience
Assuntos:
multiple sclerosis
fingolimod
expanded disability status scale (edss)
magnetic resonance imaging (mri)
cardiovascular events
therapy
Acesso em linha:http://bcn.iums.ac.ir/article-1-1412-en.html
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados